H.R. 8667

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8667 Introduced in House (IH)]

<DOC>

119th CONGRESS
2d Session
H. R. 8667

To amend titles 10 and 38, United States Code, to set the maximum cost-
sharing amount paid by an eligible covered beneficiary under the 
TRICARE program and a veteran for such selected drug, as established 
under the Social Security Act, and the maximum price of a selected drug 
procured by Federal agencies, and for other purposes.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

May 7, 2026

Mr. Vindman (for himself, Mr. Ryan, Ms. Houlahan, Mr. Keating, Ms. 
Goodlander, Mr. Deluzio, and Mr. Moulton) introduced the following 
bill; which was referred to the Committee on Veterans' Affairs, and in 
addition to the Committee on Armed Services, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
of such provisions as fall within the jurisdiction of the committee 
concerned

_______________________________________________________________________

A BILL

To amend titles 10 and 38, United States Code, to set the maximum cost-
sharing amount paid by an eligible covered beneficiary under the 
TRICARE program and a veteran for such selected drug, as established 
under the Social Security Act, and the maximum price of a selected drug 
procured by Federal agencies, and for other purposes.

Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Maximizing Individual Savings for 
Servicemembers In Obtaining Negotiated Rx Act'' or the ``MISSION Rx 
Act''.

SEC. 2. MAXIMUM PRICE FOR A SELECTED DRUG FOR THE COST-SHARING AMOUNT 
PAID BY AN ELIGIBLE COVERED BENEFICIARY UNDER TRICARE AND 
A VETERAN AND FOR FEDERAL PROCUREMENT.

(a) Pharmacy Benefits Program.--Section 1074g of title 10, United 
States Code, is amended--
(1) in subsection (a)(6), by adding at the end the 
following new subparagraphs:
``(F) Notwithstanding subparagraphs (A), (B), and (C), during any 
year a selected drug is covered under the Drug Price Negotiation 
Program established under section 1191 of the Social Security Act (42 
U.S.C. 1320f), the cost-sharing amount under this subsection during a 
year for such selected drug for an eligible covered beneficiary may not 
exceed the cost-sharing amount paid by a Medicare beneficiary for such 
selected drug in that year under part D of title XVIII of that Act (42 
U.S.C. 1395w-101 et seq.) pursuant to such Drug Price Negotiation 
Program.''; and
(2) in subsection (i), by adding at the end the following 
new paragraph:
``(5) The term `selected drug' has the meaning given such 
term in section 1192(c) of the Social Security Act (42 U.S.C. 
1320f-1(c)).''.
(b) Copayment for Medications.--Section 1722A of title 38, United 
States Code, is amended by adding at the end the following new 
subsections:
``(d) Notwithstanding subsections (a) and (b), during any year a 
selected drug is covered under the Drug Price Negotiation Program 
established under section 1191 of the Social Security Act (42 U.S.C. 
1320f), the copayment amount determined under this section during a 
year for such selected drug for a veteran may not exceed the copayment 
amount paid by a Medicare beneficiary for such selected drug in that 
year under part D of title XVIII of that Act (42 U.S.C. 1395w-101 et 
seq.) pursuant to such Drug Price Negotiation Program.
``(e) In this section, the term `selected drug' has the meaning 
given such term in section 1192(c) of the Social Security Act (42 
U.S.C. 1320f-1(c)).''.
(c) Limitation on Prices of Drugs Procured by Department and 
Certain Other Federal Agencies.--Section 8126 of title 38, United 
States Code, is amended--
(1) in subsection (a)--
(A) in paragraph (3), by striking ``; and'' and 
inserting a semicolon;
(B) in paragraph (4)(C), by striking the period and 
inserting ``; and''; and
(C) by adding at the end the following new 
paragraph:
``(5) with respect to each selected drug of the 
manufacturer procured by a Federal agency, as described in 
subsection (b), such master agreement shall be subject to the 
requirements in subsection (j).''.
(2) in subsection (g)(1), by striking ``1992'' and 
inserting ``1992, except with respect to any reference to a 
provision of such Act in paragraphs (7) and (8) of subsection 
(h) and in subsection (j)'';
(3) in subsection (h)--
(A) by redesignating paragraphs (5) and (6) as 
paragraphs (6) and (8), respectively;
(B) by inserting after paragraph (4) the following 
new paragraph:
``(5) The term `maximum fair price' has the meaning given 
such term in section 1191(c)(3) of the Social Security Act (42 
U.S.C. 1320f(c)(3)).''; and
(C) by inserting after paragraph (6), as 
redesignated by subparagraph (A), the following new 
paragraph:
``(7) The term `selected drug' has the meaning given such 
term in section 1192(c) of the Social Security Act (42 U.S.C. 
1320f-1(c)).''; and
(4) by adding at the end the following new subsections:
``(j) During any year a selected drug is covered under the Drug 
Price Negotiation Program established under section 1191 of the Social 
Security Act (42 U.S.C. 1320f), each manufacturer entering into a 
master agreement may not set the maximum price for such selected drug 
included in such master agreement at the time such master agreement is 
executed at a price exceeding the maximum fair price for such drug as 
set by such Drug Price Negotiation Program for the duration of such 
master agreement.''.
(d) Application.--
(1) In general.--The amendments made in subsection (c) 
shall apply with respect to each master agreement under section 
8126 of title 38, United States Code, covering a selected drug, 
as defined by such section, that is in effect on the date of 
the enactment of this Act or enters into force on or after such 
date.
(2) Termination of the drug price negotiation program.--
Upon termination of the Drug Price Negotiation Program 
established under section 1191 of the Social Security Act (42 
U.S.C. 1320f), each master agreement described in paragraph (1) 
shall be modified to reflect the drug price maximums as of the 
date of such modification under existing law for each selected 
drug, as defined in section 8126 of title 38, United States 
Code, as amended by subsection (c).
(e) Conforming Amendments.--Part E of the Social Security Act (42 
U.S.C. 1320f et seq.) is amended--
(1) in section 1193(a)(4)(A), by striking ``8126(h)(5)'' 
and inserting ``8126(h)''; and
(2) in section 1194(c)(6), by striking ``8126(h)(5)'' and 
inserting ``8126(h)''.
<all>